Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.9400 (4.87%) ($15.0500 - $15.9500) on Mon. Dec. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.69% (three month average) | RSI | 71 | Latest Price | $15.9400(4.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) ARKK(48%) IWO(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.845% in a week (0% probabilities). VIXM(-36%) VXX(-35%) TLT(-12%) UNG(-7%) UUP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.845% (StdDev 3.69%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
5 Day Moving Average | $15.34(3.91%) | 10 Day Moving Average | $15.43(3.31%) | 20 Day Moving Average | $14.76(7.99%) | To recent high | -0.3% | To recent low | 46.4% | Market Cap | $1.184b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |